Our contract research organization stands as your trusted partner, providing comprehensive preclinical vaccine immunogenicity efficacy testing services to safeguard the future of vaccines and protect public health.
Your Gateway to Vaccine Efficacy Assurance
With a team of infectious disease scientists and immunologists, we offer a comprehensive suite of preclinical vaccine immunogenicity efficacy testing services, tailored to your specific needs. Our expertise encompasses:
Animal Model Development: Establish an appropriate animal model in order to test the efficacy of your vaccine candidate.
Immunogenicity Assessments: Evaluate the ability of your vaccine candidate to induce a protective immune response against the target pathogen, assessing antibody titers, cellular immune responses, and humoral immune responses.
Efficacy Studies: Evaluate the ability of your vaccine candidate to protect animals from infection or disease caused by the target pathogen, employing challenge studies with appropriate animal models.
Mechanism of Action Studies: Investigate the mechanisms by which your vaccine candidate induces protective immunity, providing insights into the cellular and molecular pathways involved.
Dose-Response Studies: Determine the optimal dose of your vaccine candidate for maximum immunogenicity and efficacy, guiding clinical trial design.
Route of Administration Studies: Evaluate the efficacy of different routes of administration, such as intramuscular, subcutaneous, or intranasal, for optimal vaccine delivery and immune response.
Adjuvant Studies: Assess the effects of different adjuvants, which enhance the immune response to the vaccine antigen, optimizing vaccine efficacy.
Risk Assessment and Regulatory Support: Analyze the potential risks associated with the vaccine candidate and navigate the complexities of global regulatory requirements for vaccine development, ensuring compliance and facilitating smooth product approvals.
Expert Consulting: Gain insights from our infectious disease SMEs, immunologists, and vaccine development experts, who provide expert guidance on all aspects of preclinical vaccine immunogenicity efficacy study design, data interpretation, and regulatory compliance.
